Age (years) |
20-39 | | 41 | (28.5) |
40-59 | | 66 | (45.8) |
60-85 | | 37 | (25.7) |
Median (range) | 49.5 (20.0-85.0) | | |
Marital status |
Never married | | 22 | (15.3) |
Married | | 122 | (84.7) |
Body mass index (kg/m2) |
Underweight (<18.5) | | 5 | (3.5) |
Normal (18.5-24.9) | | 38 | (26.4) |
Overweight (25.0-29.9) | | 49 | (34.0) |
Obese (30+) | | 52 | (36.1) |
Median (range) | 27.9 (14.6-44.73) | | |
Parity |
Nullipara | | 38 | (26.4) |
1-3 | | 55 | (38.2) |
>4 | | 51 | (35.4) |
Median (range) | 3 (0-13) | | |
Medical disease |
No | | 69 | (47.9) |
Yes | | 75 | (52.1) |
Histopathology |
Serous | | 110 | (76.4) |
Non-serous | | 34 | (23.6) |
Mucinous | | 24 | (16.7) |
Endometroid | | 8 | (5.6) |
Clear cell | | 2 | (1.4) |
Stage |
I | | 42 | (29.2) |
II | | 16 | (11.1) |
III | | 69 | (47.9) |
IV | | 17 | (11.8) |
Grade |
1 | | 37 | (25.7) |
2 | | 26 | (18.1) |
3 | | 81 | (56.3) |
Residual disease |
0 | | 77 | (53.5) |
<1 | | 16 | (11.1) |
>1 | | 51 | (35.4) |
Chemotherapy |
No | | 44 | (30.6) |
Yes | | 100 | (69.4) |
Carboplatin and paclitaxel | | 82 | (56.9) |
Carboplatin alone | | 18 | (18.0) |
Disease progression |
No | | 90 | (62.5) |
Recurrence | | 49 | (34.0) |
Persistent disease | | 5 | (3.5) |
Last follow up status |
Alive | | 76 | (52.8) |
Deceased | | 68 | (47.2) |
Follow up period (years) |
Median (range) | 3.4 (2.2-17.1) | | |
Mean (SD) | 4.43 (3.90) | | |